Evidence map›Paper›PMID 39382272›Full record

ArticleJournal of bacteriology2024

Impact of high-speed nanodroplets on various pathogenic bacterial cell walls.

Yurina Tamura, Masato Kawamura, Takehiko Sato, Tomoki Nakajima, Siwei Liu, Takumi Sato, Shigeru Fujimura

Abstract read
In one paragraph

Article in Journal of bacteriology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yurina TamuraDivision of Clinical Infectious Diseases & Chemotherapy, Tohoku Medical and Pharmaceutical University, Graduate School of Pharmaceutical Sciences, Sendai, Japan.
Masato KawamuraDivision of Clinical Infectious Diseases & Chemotherapy, Tohoku Medical and Pharmaceutical University, Graduate School of Pharmaceutical Sciences, Sendai, Japan.ORCID 0000-0003-1863-1241
Takehiko SatoInstitute of Fluid Science, Tohoku University, Sendai, Japan.
Tomoki NakajimaInstitute of Fluid Science, Tohoku University, Sendai, Japan.
Siwei LiuInstitute of Fluid Science, Tohoku University, Sendai, Japan.
Takumi SatoDivision of Clinical Infectious Diseases & Chemotherapy, Tohoku Medical and Pharmaceutical University, Graduate School of Pharmaceutical Sciences, Sendai, Japan.ORCID 0000-0003-4277-0583
Shigeru FujimuraDivision of Clinical Infectious Diseases & Chemotherapy, Tohoku Medical and Pharmaceutical University, Graduate School of Pharmaceutical Sciences, Sendai, Japan.ORCID 0000-0002-7419-3293

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the development of disinfection technologies with novel mechanisms has stagnated, we demonstrate the bactericidal effects and mechanisms of high-speed nanodroplet generation technology. The first development of this technology in 2017 gushes out a water droplet of 10 nm in size at 50 m/s; however, the target surface does not become completely wet. Nanodroplets were exposed to biofilm models of IMPORTANCE: Although existing disinfection techniques demonstrate bactericidal effects through chemical reactions, concerns regarding human toxicity and environmental contamination have been raised. To the best of our knowledge, this study is the first in the world to reveal that the use of this technology, with nanodroplets of less than 100 nm, can destroy and sterilize bacterial cells by colliding with biofilm-forming bacteria at 75 MPa. Furthermore, because this technology uses only water, it can solve the problems of human toxicity and environmental contamination caused by existing disinfection techniques. Because of its minimal water usage, it can be employed for sanitation worldwide without being limited to specific regions. Our report proposes an unprecedented physical disinfection approach that utilizes a high-speed nanodroplet generation technology.

Indexed as

BiofilmsBacteriaCell WallDisinfectionEscherichia coliPseudomonas aeruginosaSerratia marcescensStaphylococcus aureusbiofilmcollisiondisinfectionnanodroplet

Identifiers

PMID39382272
PMCPMC11580407

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.